{"id":"https://openalex.org/W1966379378","doi":"https://doi.org/10.1111/dom.12175","title":"Effects of glucagon\u2010like peptide\u20101 receptor agonists on cardiovascular risk: a meta\u2010analysis of randomized clinical trials","display_name":"Effects of glucagon\u2010like peptide\u20101 receptor agonists on cardiovascular risk: a meta\u2010analysis of randomized clinical trials","alternate_titles":[],"publication_year":2013,"publication_date":"2013-07-06","ids":{"openalex":"https://openalex.org/W1966379378","doi":"https://doi.org/10.1111/dom.12175","mag":"1966379378","pmid":"https://pubmed.ncbi.nlm.nih.gov/23829656"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12175","doi":"https://doi.org/10.1111/dom.12175","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12175","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1966379378"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059413618","display_name":"Matteo Monami","orcid":"https://orcid.org/0000-0001-9349-828X","observed_orcids":["https://orcid.org/0000-0001-9349-828X"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Monami","raw_affiliation_strings":["Geriatric Cardiology; Careggi Teaching Hospital; Florence Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geriatric Cardiology; Careggi Teaching Hospital; Florence Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014780759","display_name":"Ilaria Dicembrini","orcid":"https://orcid.org/0000-0002-8163-7710","observed_orcids":["https://orcid.org/0000-0002-8163-7710"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"I. Dicembrini","raw_affiliation_strings":["Diabetes Agency; Careggi Teaching Hospital; Florence Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Agency; Careggi Teaching Hospital; Florence Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086210064","display_name":"Clara Nardini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C. Nardini","raw_affiliation_strings":["Geriatric Cardiology; Careggi Teaching Hospital; Florence Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geriatric Cardiology; Careggi Teaching Hospital; Florence Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030847814","display_name":"Irene Fiordelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"I. Fiordelli","raw_affiliation_strings":["Diabetes Agency; Careggi Teaching Hospital; Florence Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Agency; Careggi Teaching Hospital; Florence Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059685674","display_name":"Edoardo Mannucci","orcid":"https://orcid.org/0000-0001-9759-9408","observed_orcids":["https://orcid.org/0000-0001-9759-9408"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"E. Mannucci","raw_affiliation_strings":["Diabetes Agency; Careggi Teaching Hospital; Florence Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Agency; Careggi Teaching Hospital; Florence Italy","institution_ids":["https://openalex.org/I4210115393"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5059685674"],"corresponding_institution_ids":["https://openalex.org/I4210115393"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":16.6333,"has_fulltext":false,"cited_by_count":179,"citation_normalized_percentile":{"value":0.99519231,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"16","issue":"1","first_page":"38","last_page":"47"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.847000002861023},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.890999972820282},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.972000002861023},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.7440000176429749},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7900000214576721},{"id":"https://openalex.org/keywords/lipoproteins","display_name":"lipoproteins","score":0.6809999942779541},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9210000038146973},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6578658223152161},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5678635835647583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4501854181289673},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.44176191091537476},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.4323105216026306},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38683515787124634},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3262483775615692},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.09567809104919434},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.08413377404212952}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/dom.12175","doi":"https://doi.org/10.1111/dom.12175","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12175","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:23829656","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23829656","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:flore.unifi.it:2158/1063527","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2158/1063527","pdf_url":null,"source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1964435302","https://openalex.org/W1973442218","https://openalex.org/W1986215651","https://openalex.org/W2004932692","https://openalex.org/W2005501262","https://openalex.org/W2027276740","https://openalex.org/W2051279660","https://openalex.org/W2069417225","https://openalex.org/W2085458648","https://openalex.org/W2086177834","https://openalex.org/W2093104618","https://openalex.org/W2098459806","https://openalex.org/W2105391780","https://openalex.org/W2109677274","https://openalex.org/W2115653936","https://openalex.org/W2139171405","https://openalex.org/W2140682563","https://openalex.org/W2141132900","https://openalex.org/W2145270758","https://openalex.org/W2152835319","https://openalex.org/W2152969995","https://openalex.org/W2155121555","https://openalex.org/W2157665742","https://openalex.org/W2157823046","https://openalex.org/W4214661190","https://openalex.org/W4239111797"],"related_works":["https://openalex.org/W2027276740","https://openalex.org/W7159581545","https://openalex.org/W2979965402","https://openalex.org/W3213671430","https://openalex.org/W4406341531","https://openalex.org/W4413972145","https://openalex.org/W4400247231","https://openalex.org/W2889062210","https://openalex.org/W4282935205"],"abstract_inverted_index":{"AIMS:":[0],"New":[1],"drugs":[2],"for":[3,40],"type":[4,97],"2":[5,98],"diabetes":[6],"need":[7],"to":[8,107],"demonstrate":[9],"their":[10],"cardiovascular":[11,41,63,68,227],"safety,":[12],"due":[13],"regulatory":[14],"requirements":[15],"from":[16],"the":[17,45,53,56,152,181,226,235,250],"Food":[18],"and":[19,67,101,105,118,123,128,142,159,189,238],"Drug":[20],"Administration.":[21],"For":[22],"this":[23],"reason,":[24],"glucagon-like":[25],"peptide-1":[26],"receptor":[27],"agonists":[28],"(GLP-1":[29],"RA)":[30],"are":[31],"currently":[32],"undergoing":[33],"large-scale,":[34],"long-term":[35],"randomized":[36,49],"trials":[37,51,78],"specifically":[38],"designed":[39],"outcomes.":[42],"Aim":[43],"of":[44,48,55,58,82,154,183,203,229,252],"present":[46,223],"meta-analysis":[47,73,224],"clinical":[50],"is":[52],"assessment":[54],"effects":[57],"GLP-1":[59,89,157,172,204,230,242],"RA":[60,90,94,158,173,205,243],"on":[61,115,140,208,249],"major":[62],"events":[64],"(MACE),":[65],"mortality":[66,102],"risk":[69],"factors.":[70],"METHODS:":[71],"A":[72],"was":[74,206,215],"performed":[75],"including":[76],"all":[77],"with":[79,91,176,187,191,219,258],"a":[80,88,92,177,192,211,246],"duration":[81],"at":[83,145,232,254],"least":[84,146,233,255],"6":[85],"months,":[86],"comparing":[87],"non-GLP-1":[93],"agent":[95],"in":[96,151,180,185,197,217,234,239,256],"diabetes.":[99],"MACE":[100,155,184],"were":[103,130,174],"retrieved":[104],"combined":[106],"calculate":[108],"Mantel-Haenzel":[109],"odds":[110],"ratio":[111],"(MH-OR).":[112],"Furthermore,":[113],"data":[114],"endpoint":[116],"systolic":[117],"diastolic":[119],"blood":[120],"pressure,":[121],"total":[122],"high-density":[124],"lipoprotein":[125],"(HDL)":[126],"cholesterol":[127],"triglyceride":[129],"collected.":[131],"RESULTS:":[132],"Of":[133],"37":[134],"selected":[135],"trials,":[136],"33":[137],"reported":[138,144],"information":[139],"MACE,":[141,253],"25":[143],"one":[147],"event.":[148],"The":[149,222],"difference":[150],"incidence":[153,182,251],"between":[156],"comparators":[160],"did":[161],"not":[162],"reach":[163],"statistical":[164],"significance":[165],"[MH-OR":[166],"0.78":[167],"(0.54-1.13),":[168],"p":[169],"=":[170],"0.18].":[171],"associated":[175],"significant":[178,201],"reduction":[179,196],"comparisons":[186,218],"placebo":[188],"pioglitazone,":[190],"non-significant":[193,212],"trend":[194,214],"towards":[195],"DPP4i-controlled":[198],"studies.":[199],"No":[200],"effect":[202,248],"observed":[207,216],"mortality,":[209],"although":[210],"favourable":[213],"placebo.":[220,259],"CONCLUSIONS:":[221],"confirms":[225],"safety":[228],"RA,":[231],"short":[236],"term":[237],"low-risk":[240],"individuals.":[241],"could":[244],"have":[245],"beneficial":[247],"comparison":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1966379378","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":26},{"year":2016,"cited_by_count":39},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":23},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
